NextCure Historical Income Statement
| NXTC Stock | USD 0.80 0 0.12% |
Historical analysis of NextCure income statement accounts such as Selling General Administrative of 14.9 M can show how well NextCure performed in making a profits. Evaluating NextCure income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of NextCure's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining NextCure latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether NextCure is a good buy for the upcoming year.
NextCure |
About NextCure Income Statement Analysis
NextCure Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to NextCure shareholders. The income statement also shows NextCure investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
NextCure Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts NextCure generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of NextCure. It is also known as NextCure overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Interest Income
Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.Most accounts from NextCure's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into NextCure current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NextCure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For information on how to trade NextCure Stock refer to our How to Trade NextCure Stock guide.At present, NextCure's Cost Of Revenue is projected to increase significantly based on the last few years of reporting. The current year's Total Other Income Expense Net is expected to grow to about 5.9 M, whereas Depreciation And Amortization is forecasted to decline to about 3.2 M.
| 2022 | 2023 | 2024 | 2025 (projected) | Reconciled Depreciation | 4.1M | 3.9M | 4.4M | 3.7M | Total Operating Expenses | 75.9M | 67.6M | 77.8M | 56.6M |
NextCure income statement Correlations
Click cells to compare fundamentals
NextCure Account Relationship Matchups
High Positive Relationship
High Negative Relationship
NextCure income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Depreciation And Amortization | 3.4M | 4.3M | 4.1M | 3.7M | 4.2M | 3.2M | |
| Interest Expense | 209K | 183K | 77K | 5.3M | 6.1M | 6.4M | |
| Selling General Administrative | 17.0M | 20.6M | 21.7M | 19.7M | 22.7M | 14.9M | |
| Gross Profit | 22.4M | (4.3M) | (4.5M) | (3.7M) | (4.2M) | (4.0M) | |
| Other Operating Expenses | 63.6M | 70.8M | 75.9M | 67.6M | 77.8M | 56.6M | |
| Operating Income | (41.2M) | (70.8M) | (75.9M) | (67.6M) | (60.9M) | (63.9M) | |
| Net Income From Continuing Ops | (36.6M) | (69.4M) | (74.7M) | (65.6M) | (59.0M) | (62.0M) | |
| Ebit | (41.2M) | (69.3M) | (75.9M) | (62.7M) | (56.5M) | (59.3M) | |
| Research Development | 46.6M | 50.2M | 54.2M | 47.9M | 55.1M | 41.8M | |
| Ebitda | (37.8M) | (65.0M) | (71.8M) | (59.0M) | (53.1M) | (55.8M) | |
| Cost Of Revenue | 46.6K | 4.3M | 4.5M | 3.7M | 3.3M | 3.7M | |
| Total Operating Expenses | 63.6M | 70.8M | 75.9M | 67.6M | 77.8M | 56.6M | |
| Reconciled Depreciation | 3.4M | 7.2M | 4.1M | 3.9M | 4.4M | 3.7M | |
| Income Before Tax | (36.6M) | (69.4M) | (74.7M) | (62.7M) | (56.5M) | (59.3M) | |
| Total Other Income Expense Net | 4.6M | 1.4M | 1.2M | 4.9M | 5.7M | 5.9M | |
| Net Income Applicable To Common Shares | (33.7M) | (36.6M) | (69.4M) | (74.7M) | (67.3M) | (70.6M) | |
| Net Income | (33.2M) | (69.4M) | (69.4M) | (62.7M) | (56.5M) | (59.3M) | |
| Income Tax Expense | (3.7M) | (3.4M) | 7.0M | (5.3M) | (4.8M) | (4.5M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether NextCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NextCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nextcure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nextcure Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NextCure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For information on how to trade NextCure Stock refer to our How to Trade NextCure Stock guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NextCure. If investors know NextCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NextCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NextCure is measured differently than its book value, which is the value of NextCure that is recorded on the company's balance sheet. Investors also form their own opinion of NextCure's value that differs from its market value or its book value, called intrinsic value, which is NextCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NextCure's market value can be influenced by many factors that don't directly affect NextCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NextCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if NextCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NextCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.